New on the block Swiss life sciences giant Lonza group is shopping the capsules and health ingredients division, and the shortlist is full of private equity heavy players. In the running: Altar, Lone Star FundsAnd One rock capital. Expected sales price: minimum €2.5 billion (US$2.8 billion). Think of it as a showdown along the supplements, […]
These ten large-cap shares were top performers last week. Are they part of your portfolio? United Therapeutics Corporation Uthr The shares won 30.29% this week after the company announced that his Teton-2 examination evaluated the use of sprayed Tyvaso inhalation solution for the treatment of idiopathic lung fibrosis, complies with the end point of the […]